These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8486095)

  • 61. Mixed function oxidase activities of established human colon carcinoma cell lines in the activation of cyclophosphamide.
    Moskwa PS; Vadi H; Drewinko B
    Cancer Res; 1985 Nov; 45(11 Pt 1):5447-51. PubMed ID: 4053018
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Attenuation of cytogenetic damage by 2-mercaptoethanesulfonate in cultured human lymphocytes exposed to cyclophosphamide and its reactive metabolites.
    Wilmer JL; Erexson GL; Kligerman AD
    Cancer Res; 1986 Jan; 46(1):203-10. PubMed ID: 3079586
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals.
    Hansen RJ; Ludeman SM; Paikoff SJ; Pegg AE; Dolan ME
    DNA Repair (Amst); 2007 Aug; 6(8):1145-54. PubMed ID: 17485251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Up-regulation of interleukin-6 gene expression in cyclophosphamide-induced cystitis in mice: An in situ hybridization histochemical study.
    Nishii H; Nomura M; Fujimoto N; Matsumoto T
    Int J Urol; 2006 Oct; 13(10):1339-43. PubMed ID: 17010015
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
    Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
    Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of piperonyl butoxide post-treatment on acetaminophen hepatotoxicity.
    Brady JT; Montelius DA; Beierschmitt WP; Wyand DS; Khairallah EA; Cohen SD
    Biochem Pharmacol; 1988 May; 37(10):2097-9. PubMed ID: 3377813
    [No Abstract]   [Full Text] [Related]  

  • 67. Protective effects of crocetin on the bladder toxicity induced by cyclophosphamide.
    Nair SC; Panikkar KR; Parthod RK
    Cancer Biother; 1993; 8(4):339-43. PubMed ID: 7804375
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
    Crook TR; Souhami RL; Whyman GD; McLean AE
    Cancer Res; 1986 Oct; 46(10):5035-8. PubMed ID: 3463410
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differences in the effects of piperine and piperonyl butoxide on hepatic drug-metabolizing enzyme system in rats.
    Dalvi RR; Dalvi PS
    Drug Chem Toxicol; 1991; 14(1-2):219-29. PubMed ID: 1889377
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute effects of cyclophosphamide on rat urinary bladder muscle.
    Bonikos DS; Koss LG
    Arch Pathol; 1974 Apr; 97(4):242-5. PubMed ID: 4814709
    [No Abstract]   [Full Text] [Related]  

  • 71. L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.
    Roberts JC; Francetic DJ; Zera RT
    Cancer Chemother Pharmacol; 1991; 28(3):166-70. PubMed ID: 1855273
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of inhibitors of eicosanoid synthesis upon lymphocyte proliferation.
    Calder PC; Bond JA; Newsholme EA
    Biochem Soc Trans; 1991 Apr; 19(2):88S. PubMed ID: 1889681
    [No Abstract]   [Full Text] [Related]  

  • 73. The in vitro activation of cyclophosphamide in the Hydra Developmental Toxicology Assay.
    Newman LM; Johnson EM; Giacobbe RL; Fu LJ
    Fundam Appl Toxicol; 1990 Oct; 15(3):488-99. PubMed ID: 2258013
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential toxicities of cyclophosphamide and its glutathione metabolites to A549 cells.
    Perry CS; Liu X; Lund LG; Whitman CP; Kehrer JP
    Toxicol In Vitro; 1995 Feb; 9(1):21-6. PubMed ID: 20650059
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolism and pulmonary toxicity of cyclophosphamide.
    Patel JM
    Pharmacol Ther; 1990; 47(1):137-46. PubMed ID: 2195554
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of ifosfamide-induced urotoxicity by disulfiram in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1989 Jan; 49(1):147-50. PubMed ID: 2724678
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Depletion by 1,2-dibromoethane, 1,2-dibromo-3-chloropropane, tris(2,3-dibromopropyl)phosphate, and hexachloro-1,3-butadiene of reduced non-protein sulfhydryl groups in target and non-target organs.
    Kluwe WM; McNish R; Smithson K; Hook JB
    Biochem Pharmacol; 1981 Aug; 30(16):2265-71. PubMed ID: 6794573
    [No Abstract]   [Full Text] [Related]  

  • 78. Prevention of acrolein-induced bladder injury by pentosanpolysulfate.
    Kalota SJ; Stein PC; Parsons CL
    J Urol; 1992 Jul; 148(1):163-6. PubMed ID: 1377288
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functional IgG Autoantibodies against Autonomic Nervous System Receptors in Symptomatic Women with Silicone Breast Implants.
    Talalai E; Gorobets D; Halpert G; Tsur AM; Heidecke H; Levy Y; Watad A; Blank M; Michaelevski I; Shoenfeld Y; Amital H
    Cells; 2023 May; 12(11):. PubMed ID: 37296631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antigenotoxic effect of nordihydroguaiaretic acid against chlormadinone acetate-induced genotoxicity in mice bone-marrow cells.
    Siddique YH; Ara G; Beg T; Afzal M
    J Nat Med; 2008 Jan; 62(1):52-6. PubMed ID: 18404342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.